Nanobiotix S.A. (NBTX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Nanobiotix S.A., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Nanobiotix S.A. (NBTX) has returned 33.52% so far this year and 762.29% over the past 12 months.

Based on dividend-adjusted daily data since Dec 11, 2020, NBTX's average daily return is +0.28%, while the average monthly return is +4.06%. At this rate, your investment would double in approximately 1.5 years.

Historically, 45% of months were positive and 55% were negative. The best month was May 2023 with a return of +114.0%, while the worst month was Apr 2023 at -39.3%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 12 months.

On a daily basis, NBTX closed higher 43% of trading days. The best single day was May 5, 2023 with a return of +229.1%, while the worst single day was Apr 25, 2023 at -40.0%.

Nanobiotix S.A. has an annualized alpha of 77.59%, beta of 1.03, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since December 14, 2020.

• This stock captured 110.90% of S&P 500 Index gains and 109.37% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NBTX ranks 99 for risk / return — in the top 99% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Nanobiotix S.A. (NBTX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Nanobiotix S.A.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Nanobiotix S.A. was 89.94%, occurring on May 1, 2023. Recovery took 608 trading sessions.

The current Nanobiotix S.A. drawdown is 23.08%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Nanobiotix S.A. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Nanobiotix S.A. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.